| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 01/06/1994 | CA2120745A1 A combination of anti-erbb-2 monoclonal antibodies and method of using |
| 01/06/1994 | CA2116575A1 Adaptogenic agent |
| 01/06/1994 | CA2112482A1 Polymer-bound paclitaxel derivatives |
| 01/05/1994 | EP0577215A1 Surface modified anticancer nanoparticles |
| 01/05/1994 | EP0577083A1 7,8-cyclopropataxanes with antitumor action |
| 01/05/1994 | EP0577082A1 Fluoro taxols with antitumor activity |
| 01/05/1994 | EP0576974A1 Benzyliden-quinuclidinones as sunscreen agents |
| 01/05/1994 | EP0576898A2 Linear peptides |
| 01/05/1994 | EP0576669A1 Novel methods and compositions for treatment of angiogenic diseases |
| 01/05/1994 | EP0576619A1 1,2-dithiole-3-thione derivative-based therapeutical compositions. |
| 01/05/1994 | EP0576609A1 Receptors for bombesin-like peptides |
| 01/05/1994 | EP0394262B1 Platinum compounds suitable for use as pharmaceuticals |
| 01/05/1994 | DE4221961A1 22-En-25-oxa-Derivate in der Vitamin D-Reihe, Verfahren zu ihrer Herstellung, diese Derivate enthaltenen pharmazeutische Präparate sowie deren Verwendung als Arzneimittel 22-Ene-25-oxa derivatives in the vitamin D series, process for their preparation, these derivatives contained pharmaceutical preparations and their use as medicaments |
| 01/05/1994 | DE4220757A1 Derivate in der Vitamin D-Reihe mit Modifikationen in der 20-Position, Verfahren zu ihrer Herstellung, Zwischenprodukte für dieses Verfahren, diese Derivate enthaltende pharmazeutische Präparate sowie deren Verwendung zur Herstellung von Arzneimitteln Derivatives in the vitamin D series with modifications in the 20-position, processes for their preparation, intermediates for this process, pharmaceutical preparations containing these derivatives and their use for the preparation of medicaments |
| 01/05/1994 | CN1080172A Purified tetrahydropyrimidine derivatives and pharmaceutical compositions comprising them |
| 01/05/1994 | CN1023409C Production method of nutritive liquid |
| 01/04/1994 | US5276217 Cyclic anti-tumor promoter compounds, compositions and methods for production and use |
| 01/04/1994 | US5276177 Physiologically active substance |
| 01/04/1994 | US5276051 Arylethylamine compounds |
| 01/04/1994 | US5276049 Cyclic urea derivatives, pharmaceutical compositions containing these compounds and methods of using the same |
| 01/04/1994 | US5276019 Inhibitors for replication of retroviruses and for the expression of oncogene products |
| 12/29/1993 | EP0576349A1 Indolizine derivatives, process of preparation and use for the preparation of aminoalkyloxybenzenesulfonylindolizine compounds with pharmaceutical activity |
| 12/29/1993 | EP0576230A1 2'-deoxy-2', 2'-difluoro(4-substituted pyrimidine) nucleosides having antiviral and anti-cancer activity and intermediates |
| 12/29/1993 | EP0576227A2 2'-Deoxy-2',2'-difluoro(2,6,8-substituted) purine nucleosides having anti-viral and anti-cancer activity and intermediates |
| 12/29/1993 | EP0575890A1 Fumaric acid salts of quinoline derivatives to overcome MDR in cancer treatment |
| 12/29/1993 | EP0575844A2 Hydroxamic acid derivatives and pharmaceutical compositions thereof |
| 12/29/1993 | EP0575557A1 Method of inhibiting padgem-mediated interactions using an inhibitor comprising a 2,6 sialic acid component |
| 12/29/1993 | EP0575526A1 6,9 BIS(SUBSTITUTED-AMINO)BENZO g]ISOQUINOLINE-5,10-DIONES |
| 12/29/1993 | EP0575321A1 Synergistic tumor therapy with combinations of biologically active anti-tumor antibodies and chemotherapy |
| 12/29/1993 | EP0516729B1 N-phenyl n-alkoxycarbonylalkyl glycinamides, preparation method and drugs containing them |
| 12/29/1993 | EP0318562B1 Method of selectively inhibiting hiv |
| 12/29/1993 | EP0192671B1 Minactivin |
| 12/29/1993 | CN1079971A Polymer-bound taxol derivatives |
| 12/29/1993 | CN1079898A Oxaspiro |2,5¨ octane derivative |
| 12/28/1993 | US5274076 N-alpha-acetyl,N-epsilon(histamine-succinyl-glycl)-L-lysyl-L -tyrosyl-N-epsilon(histamine-succinyl-glycyl)-L-lysylamide |
| 12/28/1993 | US5273971 13-alkyl-11β-phenylgonanes |
| 12/28/1993 | US5273963 Compositions and methods for treating small cell and nonsmall cell lung cancers |
| 12/28/1993 | US5273745 Virus-modified tumor vaccines for immunotherapy of tumor metastases |
| 12/28/1993 | CA1325695C Peptides with pharmaceutical activity |
| 12/28/1993 | CA1325591C Method for treating malignancy and autoimmune disorders in humans |
| 12/26/1993 | CA2098166A1 Hydroxamic acid derivatives |
| 12/24/1993 | CA2098982A1 Indolizine derivatives, process of preparation and use for the preparation of aminoalkoxybenzenesulphonylindolizine compounds with pharmaceutical activity |
| 12/23/1993 | WO1993025700A1 Monoclonal antibodies to glycoprotein p |
| 12/23/1993 | WO1993025694A1 Inhibitors of ced-3 and related proteins |
| 12/23/1993 | WO1993025690A1 Recombinant pseudomonas exotoxin with increased activity |
| 12/23/1993 | WO1993025673A1 In vivo gene therapy with intron-free sequence of interest |
| 12/23/1993 | WO1993025667A1 D-enzyme compositions and methods of their use |
| 12/23/1993 | WO1993025536A1 1,2,3-triazole and imidazole compounds and their antitumor use |
| 12/23/1993 | WO1993025530A2 Vinyl arenas having retinoid-like activity |
| 12/23/1993 | WO1993025224A1 Pharmaceutical preparations for inhibiting tumours associated with prostate adenocarcinoma, stomach cancer and breast cancer |
| 12/23/1993 | CA2137819A1 Vinyl arenas having retinoid-like activity |
| 12/23/1993 | CA2136724A1 Recombinant pseudomonas exotoxin with increased activity |
| 12/23/1993 | CA2134752A1 Monoclonal antibodies to glycoprotein p |
| 12/23/1993 | CA2098876A1 2'-deoxy-2',2-'difluoro(2,6,8-substituted)purine nucleosides having anti-viral and anti-cancer activity and intermediates |
| 12/23/1993 | CA2098875A1 2'-deoxy-2'-2'-difluoro(4-substituted pyrimidine)nucleosides having anti-viral and anti-cancer activity and intermediates |
| 12/22/1993 | EP0575210A1 Azole derivatives, pharmaceutical compositions containing the same, and methods for treating mycosis and estrogen-dependent diseases |
| 12/22/1993 | EP0574955A1 Production and use of IL-6 |
| 12/22/1993 | EP0574857A1 Compounds 31668P and 31668U, a process for their production and their use |
| 12/22/1993 | EP0574808A1 Amidine-biphenyl derivatives, process for their production & medical preparation containing them |
| 12/22/1993 | EP0574758A1 Hydroxamic acid derivatives as collagenase inhibitors |
| 12/22/1993 | EP0574512A1 Redirection of cellular immunity by receptor chimeras |
| 12/22/1993 | EP0574414A1 LIGAND GROWTH FACTORS THAT BIND TO THE erbB-2 RECEPTOR PROTEIN AND INDUCE CELLULAR RESPONSES |
| 12/22/1993 | EP0574395A1 Cytokine immunoconjugates |
| 12/22/1993 | EP0440633B1 Pharmaceutical for treating tumors in humans and method for making it |
| 12/22/1993 | CN1079732A Pharmaceutical compounds |
| 12/21/1993 | US5272263 DNA sequences encoding vascular cell adhesion molecules (VCAMS) |
| 12/21/1993 | US5272253 Cluster conjugates of drugs with antibodies |
| 12/21/1993 | US5272171 Phosphonooxy and carbonate derivatives of taxol |
| 12/21/1993 | US5272151 Aminoacyl and oligopeptidyl derivatives of allopurinol exhibiting immunostimulatory activity, and pharmaceutical formulations containing these substances |
| 12/21/1993 | US5272141 Contraceptive and menstrual cycle controlling drug having oncostatic therapeutic properties for treatment of mammary tumors and melanomas, and method therefor |
| 12/21/1993 | US5271941 Antisense oligonucleotides of human regulatory subunit RI.sub.α of cAMP-dependent protein kinases |
| 12/19/1993 | CA2098535A1 Linear peptides |
| 12/15/1993 | EP0574195A1 Antitumoral aza- and diazaanthracenes |
| 12/15/1993 | EP0573977A2 Novel estradiol derivative-chlorambucil conjugate, process for preparing the same, and pharmaceutical composition |
| 12/15/1993 | EP0573976A1 Anthracyclin analogue, compound UCEG |
| 12/15/1993 | EP0573617A1 Modulation of cellular response to external stimuli |
| 12/15/1993 | CN1079400A Anti-tumor method and anti-tumor agent |
| 12/15/1993 | CN1079391A Preparation method of arsenical capable of applying to cancer focus |
| 12/15/1993 | CA2074665A1 Process for labeling substances with technetium or rhenium |
| 12/15/1993 | CA2060537A1 Msh peptide derivatives |
| 12/14/1993 | US5270335 Administering a dioxabicyclo(3.3.0)octane |
| 12/14/1993 | US5270330 2-nitroimidazole derivative, production thereof, and radiosensitizer containing the same as active ingredient |
| 12/14/1993 | US5270329 1-arylsulfonyl-imidazolidin-2-one derivatives |
| 12/14/1993 | US5270171 Cancer-associated SCM-recognition factor, preparation and method of use |
| 12/14/1993 | US5270047 Local delivery of dipyridamole for the treatment of proliferative diseases |
| 12/14/1993 | US5270041 Sterols, their fatty acid esters and glucosides; processes for their preparation; spontaneously dispersible agents containing these compounds, and their use for treatment of tumors |
| 12/14/1993 | CA1325205C Substituted flavanoid compounds, their salts, their manufacture and medicines containing these materials |
| 12/12/1993 | CA2098168A1 Hydroxamic acid derivatives |
| 12/12/1993 | CA2098158A1 Biphenyl derivatives, pharmaceutical compositions containing these compounds and processes for preparing them |
| 12/12/1993 | CA2097137A1 Novel estradiol derivative-chlorabucil conjugate, process for preparing the same, and pharmaceutical compositions |
| 12/09/1993 | WO1993024647A1 Anti-idiotypic monoclonal antibodies against the lewis y-specific monoclonal antibody br55-2 and their uses |
| 12/09/1993 | WO1993024643A1 Farnesyltransferase inhibitors oh-4652 and production thereof |
| 12/09/1993 | WO1993024640A2 Methods and compositions for in vivo gene therapy |
| 12/09/1993 | WO1993024529A1 Retinal pigmented epithelium derived neurotrophic factor |
| 12/09/1993 | WO1993024527A1 Peptide inhibitors of selectin binding |
| 12/09/1993 | WO1993024525A1 PEPTIDES OF HUMAN p53 PROTEIN FOR USE IN HUMAN T CELL RESPONSE INDUCING COMPOSITIONS, AND HUMAN p53 PROTEIN-SPECIFIC CYTOTOXIC T-LYMPHOCYTES |
| 12/09/1993 | WO1993024510A1 Phosphotriester-type biologically active compounds |
| 12/09/1993 | WO1993024491A1 Indolocarbazole imides and their use |
| 12/09/1993 | WO1993024475A1 Sulphamide derivatives as metalloproteinase inhibitors |
| 12/09/1993 | WO1993024451A1 Desferrioxamine-b salts and their use as orally effective iron chelators |